Medacta Group SA's next confirmed earnings release is scheduled for March 12, 2027.
| Earnings Date | 3/12/2027 |
As of June 30, 2026, Medacta Group SA has 19.95M shares outstanding.
| Shares Outstanding | 19.95M |
As of June 30, 2026, Medacta Group SA maintains a current ratio of 2.10, meaning it holds 2.1x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 2.10 |
| Quick Ratio | 0.16 |
| Debt / Equity | 65.69 |
These figures cover the twelve months ended June 30, 2026.
| Employee Count | 2,165.00 |
As of the close on November 5, 2026, Medacta Group SA's stock has gained approximately 72.90% over the past 52 weeks.
| 52-Week Price Change | 72.90% |
As of June 30, 2026, Medacta Group SA holds 42.62M in cash and equivalents against 362.60M in total debt, resulting in a net debt position of 254.79M. Total book value stands at 551.96M, with working capital of 297.27M providing operational flexibility.
| Cash & Cash Equivalents | 42.62M |
| Total Debt | 362.60M |
| Net Debt | 254.79M |
| Equity (Book Value) | 551.96M |
| Book Value Per Share | 27.67 |
| Working Capital | 297.27M |
Already premium?